Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Rajwinder Kaur is Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. She has extensive experience in teaching and research and has held academic and research positions, including appointment as a DST Women Scientist at Panjab University, Chandigarh. Her research focuses on computational drug design, fused heterocyclic compounds, nanomedicine, and the application of artificial intelligence in pharmaceutical research, with particular interests in inflammation, asthma, and neurological disorders. Dr. Kaur has contributed extensively to the scientific literature through scholarly publications, book chapters, and editorial work. She is actively involved in academic and research initiatives that promote innovation in pharmaceutical sciences and interdisciplinary drug discovery. She is a Senior Member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a Life Member of the Indian Pharmacy Graduate Association (IPGA). Shikha Baghel Chauhan is Associate Professor in the Department of Industrial Pharmacy at Amity Institute of Pharmacy, Amity University, Noida, India. She has extensive experience spanning academia and the pharmaceutical sector. Her research interests include novel drug delivery systems, transdermal drug delivery, nanocarrier-based formulations, and herbal drug development. In addition to her teaching and research activities, Dr. Chauhan is engaged in scientific publishing and academic outreach, including educational initiatives that support pharmacy education and professional development. She has contributed to the pharmaceutical sciences literature through scholarly publications, books, book chapters, and intellectual property development. Her work focuses on advancing formulation science and drug delivery approaches to address contemporary healthcare challenges. Dr. Indu Singh is an Assistant Professor at the School of Pharmacy, Graphic Era Hill University, Dehradun. She previously served at K. R. Mangalam University, Gurugram, as an Assistant Professor in Pharmacology and a Research Communication Officer. A Pharmacologist and Biomedical Scientist, Dr. Singh earned her PhD from the University of Delhi, and her postgraduation in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where she was a Gold Medalist.Her research focuses on nanomedicine development for combating Antimicrobial Resistance (AMR) and Biofilm-Associated Infections (BAI), as well as therapeutic strategies for Autism Spectrum Disorder (ASD) targeting inflammatory markers. She has 15+ publications, serves as an editor and reviewer for international journals, and has received multiple honors, including the Young Scientist Award from Kasetsart University, Thailand, and seven national awards. Dr. Singh has organized and contributed to national and international workshops, including the DST INDO-ASEAN Workshop, and has mentored PG, UG, and Ph.D. students. She has also edited one academic book.Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.

Select Guide Rating

• 1. Introduction to Brain Tumors and Nanotechnology: Overview, Challenges, and Potential Role in Crossing the Blood-Brain Barrier2. Molecular Mechanisms of Brain Tumorigenesis and Nanotechnology3. The Role of Nanotechnology in Tumor Microenvironment Studies4. Targeting Angiogenesis in Brain Tumors with Nanotechnology5. Nanotechnology in Immune Modulation Against Brain Tumors6. Nanomedicine for Drug Delivery in Brain Tumors: Targeting the Blood-Brain Barrier for Enhanced Efficacy7. Functionalized Nanocarriers for Targeted and Combination Therapy in Brain Tumors8. Current Innovations in Nanotechnology Clinical Trials for Brain Tumors9. Nanotechnology in Molecular Imaging for Brain Tumor10. Nanosensors for Early Detection of Brain Tumors11. Therapeutic Innovations and Radiation: Combining Nanotechnology with Conventional Therapies12. Multi-modal Approaches: Nanotechnology Combined with Conventional Therapies13. Case Studies: Successful Applications of Nanotechnology in Brain Tumor Therapy14. Routes of Nanoparticle Delivery and Targeting in Brain Tumors15. Personalized Nanomedicine: Tailoring Treatments for Brain Tumor Patients16. Regulatory Challenges and Future Prospects for Nanotechnology in Brain Tumors17. Innovative Approaches to Overcoming Drug Resistance in Brain Tumors via Nanotechnology18. Future Technology Trends in Nanotechnology for Brain Tumors: Exploring emerging technologies and materials in nanotechnology19. Bridging Molecular Mechanisms and Nanotechnology in Brain Tumors